EFDA

Ethiopia Set to Build Vaccine Manufacturing Plant

Ethiopia Set to Build Vaccine Manufacturing Plant

Ethiopia is finalizing the design work for a vaccine manufacturing plant, a major step toward boosting domestic vaccine production and strengthening the country's pharmaceutical sector, the Ethiopian Food and Drug Authority (EFDA) has announced. EFDA Director General Heran Gerba said the facility will be developed under Ethiopian Investment Holdings (EIH) with the objective of increasing vaccine availability, improving health security, and reducing the country's reliance on imported vaccines. According to Heran, the project aligns with the African Union's target of enabling Africa to produce 60 percent of its vaccine requirements by 2040. The authority also said it has introduced new…
Read More
WHO Grants Ethiopia Level 3 Drug Regulation Status

WHO Grants Ethiopia Level 3 Drug Regulation Status

The Ethiopian Food and Drug Authority (EFDA) has achieved the World Health Organization’s (WHO) Maturity Level 3 (ML3) for its medicines regulatory system, a recognition that places Ethiopia among a select group of African nations with stable and well-functioning regulatory systems. The Africa Centres for Disease Control and Prevention (Africa CDC) confirmed the milestone on Thursday, commending Ethiopia for strengthening its oversight of the safety, quality, and effectiveness of medicines. With this achievement, Ethiopia joins countries such as Egypt, Ghana, Nigeria, South Africa, Tanzania, Zimbabwe, Senegal, and Rwanda, which have also attained WHO ML3 status. The recognition is considered a…
Read More